US IPO Week Ahead: Markets set for a quiet week after year’s first sizable IPO
...read more
2025 US Market Review
Download Now
Get the Preview
IPO Center
Research IPOs and Discover New Stocks
IPOS IN THE NEWS
US IPO Weekly Recap: Aktis Oncology leads as first sizable 2026 IPO
Three IPOs and five SPACs priced this week. Six IPOs and two SPACs submitted initial filings. In the first sizable deal of 2026, solid tumor biotech Aktis Oncology (AKTS) priced its upsized IPO at the high end of the range to raise $318 million at a $1.0...read more
Immuno-responsive cancer biotech Eikon Therapeutics files for an estimated $300 million IPO
Eikon Therapeutics, a Phase 2 biotech developing therapies for immuno-responsive cancers, filed on Friday with the SEC to raise up to $100 million in an initial public offering. However, the deal size is likely a placeholder for an offering that we estimate...read more
IPO ETF
U.S. IPO Performance
Nothing more on the IPO calendar for the week of 1/5/2026.
View recent IPO activity
to see which US IPOs
and International IPOs
were added to our ETFs.
IPO PRO TIP
Create custom screens and filters to see when IPOs are coming up. Explore full IPO Calendar
| Ticker | Company | Ticker | Offer Date | Deal Size ($M) | Current Price | Today's Change | Return from IPO |
|---|---|---|---|---|---|---|---|
| AKTS | Aktis Oncology | AKTS | 01/08/26 | $318 | $22.40 |
$0.00
(0.0%)
|
24.4% |
| BUDA | Buda Juice | BUDA | 01/07/26 | $20 | $8.15 |
$0.00
(0.0%)
|
8.7% |
| ANDG | Andersen Group | ANDG | 12/16/25 | $176 | $24.29 |
$0.00
(0.0%)
|
51.8% |
IPO PRO TIP
The IPO price is the price the underwriters will sell stock to institutional and accredited investors. Learn more at IPO University
Uncover New IPO Opportunities
Enhance your knowledge with IPO Pro. Screen for new stocks and find opportunities that others miss.
Start your 7-day trial of IPO Pro
